1.
J. epilepsy clin. neurophysiol
;
11(1): 37-38, Mar. 2005. tab
Artigo
em Inglês
| LILACS
| ID: lil-426243
RESUMO
Carbamazepine is probably the most widely anti-epileptic drug prescribed in the world. Thus, potentially serious adverse events must become well known by the medical community. A severe carbamazepine-induced hyperlipidemia after short-term exposure to the drug is described in a single case report. The severe hypertriglyceridemia presented by the patiet may be justified as a paradoxical effect, distinguished from the after long-term exposure effect reported in the literature as an adverse drug event. The importance of a lipid profile study in patients facing long-term carbamazepine therapy is emphasized, due to the potential long-term noxious effects of hyperlipidemias